Indications and uses
first aid to help prevent infection in minor: cuts scrapes burns
first aid to help prevent infection in minor: cuts scrapes burns
clean the affected area and dry thoroughly apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily may be covered with a sterile bandage
To open: unscrew cap, pull tab to remove foil seal store at 20° to 25°C (68° to 77°F) see carton or tube crimp for lot number and expiration date
Drug Facts
| Active ingredients (each gram contains) | Purpose |
|---|---|
| Bacitracin zinc 400 units | First aid antibiotic |
| Neomycin sulfate 3.5 mg | First aid antibiotic |
| Polymyxin B sulfate 5,000 units | First aid antibiotic |
first aid to help prevent infection in minor:
For external use only.
Do not use
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
white petrolatum
Call 1-866-923-4914
DIST. BY MEIJER
DISTRIBUTION, INC.
2929 WALKER AVE NW
GRAND RAPIDS, MI 49544
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 204602 | bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment | PSN | 2 |
| 204602 | bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment | SCD | 2 |
| 204602 | bacitracin 400 UNT / neomycin 3.5 MG (as neomycin sulfate 5 MG) / polymyxin B 5000 UNT per GM Topical Ointment | SY | 2 |
| Class | Version | Type | Effective |
|---|---|---|---|
| BACITRACIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NEOMYCIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| POLYMYXIN B Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 99e684e6-f435-feb8-d2bb-3a546f1cb768 | Product name | 2 | 20161117 |
| 25340b3b-3e4c-4ff8-abf6-3e62ec46bd0c | Product name | 1 | 20160603 |
| 2d352c73-a357-4193-a4de-dfdf9a2ac8e4 | Product name | 1 | 20150819 |
| b045ad64-0f28-9a02-2f9b-b34d94fb2278 | Product name | 1 | 20140508 |
| b6082387-f592-1148-0844-bd068fd213fb | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 41250-500-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-d8bf-f424-e053-dadaa90a57ce | meijer ™ Triple Antibiotic |
| 41250-500-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-d8bf-f424-e053-dadaa90a57ce | meijer ™ Triple Antibiotic |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41250-500-02 | meijer Triple Antibiotic | 1 in 1 CARTON | OINTMENT | 1 | 2 | |
| 41250-500-02 | meijer Triple Antibiotic | 28.4 g in 1 TUBE | OINTMENT | 28.4 | 2 | |
| 41250-500-03 | meijer Triple Antibiotic | 60 g in 1 TUBE | OINTMENT | 60 | 2 | |
| 41250-500-03 | meijer Triple Antibiotic | 1 in 1 CARTON | OINTMENT | 1 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Bacitracin zinc | ACTIVE INGREDIENT | 89Y4M234ES | 2 | |
| Neomycin sulfate | ACTIVE INGREDIENT | 057Y626693 | 2 | |
| Polymyxin B sulfate | ACTIVE INGREDIENT | 19371312D4 | 2 | |
| Bacitracin | ACTIVE MOIETY | 58H6RWO52I | 2 | |
| Neomycin | ACTIVE MOIETY | I16QD7X297 | 2 | |
| Polymyxin B | ACTIVE MOIETY | J2VZ07J96K | 2 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 41250-500 | 41250-500-02, 41250-500-03 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Bacitracin zinc | 89Y4M234ES | ACTIM |
| Neomycin sulfate | 057Y626693 | ACTIM |
| Polymyxin B sulfate | 19371312D4 | ACTIM |
| petrolatum | 4T6H12BN9U | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 26e3b5b8-6806-4176-9f3b-b8bf2bed9b6b | 80ba72f6-8930-424d-bc18-e1bb47d6d548 | 2013-04-11 | Warnings | 26e3b5b8-6806-4176-9f3b-b8bf2bed9b6b 80ba72f6-8930-424d-bc18-e1bb47d6d548 |
Adverse event summaries are temporarily unavailable. Other product information remains available.